- Issuer ticker
-
FULC
- Reported as of
-
07 Nov 2022
- Net transaction value
-
$0
- SEC form
-
3
- Accepted by SEC
-
09 Nov 2022, 15:10:10 UTC
Filing notes and source
Key filing fact
Santiago Arroyo filed Form 3 for Fulcrum Therapeutics, Inc. (FULC) on 09 Nov 2022.
Key facts
- This page summarizes Santiago Arroyo's Form 3 filing for Fulcrum Therapeutics, Inc. (FULC).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Nov 2022, 15:10.
Change
- Previous filing in this sequence was filed on 07 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
Ownership activity is grounded in SEC Form 3 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FULC
holding
No securities are beneficially owned
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 0
- Date
- 07 Nov 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
SEC remarks
Exhibit Index: 24.1 Power of Attorney